Clinical Trials Browser

Phase 1/2 × Dasatinib × Dermatologic × Clear all

NCT00597038 2013-12-16

A Phase I/II Study of Dasatinib and Dacarbazine

Phase 1/2 Completed

50 enrolled 11 charts

Melanoma